Immunotherapy for psoriasis: from serendipity to selectivity

被引：21

作者：

Griffiths, CEM ^{[1
]}

机构：

[1] Univ Manchester, Hope Hosp, Sch Med, Dermatol Ctr, Manchester M6 8HD, Lancs, England

来源：

LANCET | 2002年 / 359卷 / 9303期

关键词：

D O I：

10.1016/S0140-6736(02)07536-0

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

引用

收藏

页码：279 / 280

页数：2

相关论文

共 16 条

[1]

Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells [J].

Abrams, JR ;

Kelley, SL ;

Hayes, E ;

Kikuchi, T ;

Brown, MJ ;

Kang, SW ;

Lebwohl, MG ;

Guzzo, CA ;

Jegasothy, BV ;

Linsley, PS ;

Krueger, JG .

JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (05) :681-693

[2]

Interleukin 10 treatment of psoriasis -: Clinical results of a phase 2 trial [J].

Asadullah, K ;

Döcke, WD ;

Ebeling, M ;

Friedrich, M ;

Belbe, G ;

Audring, H ;

Volk, HD ;

Sterry, W .

ARCHIVES OF DERMATOLOGY, 1999, 135 (02) :187-192

[3]

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial [J].

Chaudhari, U ;

Romano, P ;

Mulcahy, LD ;

Dooley, LT ;

Baker, DG ;

Gottlieb, AB .

LANCET, 2001, 357 (9271) :1842-1847

[4]

Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes [J].

Ellis, CN ;

Krueger, GG .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (04) :248-255

[5]

CYCLOSPORINE FOR PLAQUE-TYPE PSORIASIS - RESULTS OF A MULTIDOSE, DOUBLE-BLIND TRIAL [J].

ELLIS, CN ;

FRADIN, MS ;

MESSANA, JM ;

BROWN, MD ;

SIEGEL, MT ;

HARTLEY, AH ;

ROCHER, LL ;

WHEELER, S ;

HAMILTON, TA ;

PARISH, TG ;

ELLISMADU, M ;

DUELL, E ;

ANNESLEY, TM ;

COOPER, KD ;

VOORHEES, JJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (05) :277-284

[6]

Fortune DG, 1997, BRIT J DERMATOL, V137, P755

[7]

Krueger G, 2001, ARCH DERMATOL, V137, P280

[8]

Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cells by administration of humanized anti-Tac antibody to patients with psoriasis [J].

Krueger, JG ;

Walters, IB ;

Miyazawa, M ;

Gilleaudeau, P ;

Hakimi, J ;

Light, S ;

Sherr, A ;

Gottlieb, AB .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 43 (03) :448-458

[9]

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial [J].

Mease, PJ ;

Goffe, BS ;

Metz, J ;

VanderStoep, A ;

Finck, B ;

Burge, DJ .

LANCET, 2000, 356 (9227) :385-390

[10]

MUELLER W, 1979, NEW ENGL J MED, V301, P555